Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East

Abdul K. Siraj, Muna Ibrahim, Maha Al-Rasheed, Rong Bu, Prashant Bavi, Zeenath Jehan, Jehad Abubaker, Walid Murad, Fouad Al-Dayel, Adnan Ezzat, Hassan El-Solh, Shahab Uddin, Khawla Al-Kuraya

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Diffuse large B cell lymphoma (DLBCL) is one of the most common non-Hodgkin's lymphoma types. Methylenetetrahydrofolate reductase (MTHFR) balances the pool of folate coenzymes in one carbon metabolism of deoxyribonucleic acid (DNA) synthesis and methylation; both are implicated in carcinogenesis of many types of cancer including lymphoma. Two common variants in the MTHFR gene (C677T and A1298C) have been associated with reduced enzyme activity, thereby making MTHFR polymorphisms a potential candidate as a cancer-predisposing factor. The O6 methylguanine DNA methyltransferase (MGMT) and fragile histidine triad (FHIT) genes are transcriptionally silenced by promoter hypermethylation in DLBCL. These genetic differences are highly race specific and have never been screened in the Saudi DLBCL patients. We conducted a hospital-based case-control study including 160 DLBCL cases and 511 Saudi control samples analyzing the MTHFR C677T and A1298C functional polymorphisms by the restriction fragment length polymorphism method and their association with MGMT and FHIT genes promoter hypermethylation. Our data demonstrated that Saudi individuals carrying MTHFR genotype 1298CC (p<0.001) and the 1298C allele (p=0.012) had 4.23 and 1.73-fold higher risk of developing DLBCL, respectively. Additionally, combined genotype CCCC (MTHFR 677CC+MTHFR 1298CC) was associated with 3.489-fold, and CTCC (MTHFR 677 CT+1298CC) was related to 9.515-fold higher risk, compared with full MTHFR enzyme activity. No significant association between MTHFR variant genotypes and methylation of MGMT and FHIT genes were observed. Our findings suggested that polymorphisms of MTHFR enzyme genes might be associated with the individual susceptibility to develop DLBCL. Additionally, the results indicated that MTHFR variants were not related to MGMT or FHIT hypermethylation in DLBCL.

Original languageEnglish
Pages (from-to)887-895
Number of pages9
JournalAnnals of Hematology
Volume86
Issue number12
DOIs
Publication statusPublished - 1 Dec 2007

Keywords

  • Diffuse large B cell lymphoma
  • FHIT
  • Methylation
  • MGMT
  • MTHFR

Fingerprint Dive into the research topics of 'Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East'. Together they form a unique fingerprint.

  • Cite this

    Siraj, A. K., Ibrahim, M., Al-Rasheed, M., Bu, R., Bavi, P., Jehan, Z., Abubaker, J., Murad, W., Al-Dayel, F., Ezzat, A., El-Solh, H., Uddin, S., & Al-Kuraya, K. (2007). Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East. Annals of Hematology, 86(12), 887-895. https://doi.org/10.1007/s00277-007-0350-2